Digital Transformation & Artificial Intelligence

Objectives

Reasons to attend this conference:

• You will get an overview of the current state of digital transformation and use of artificial intelligence in the pharmaceutical industry.
• You will learn how efficiency can be improved and quality can be supported through the implementation of digitalisation.
• In various case studies of pharmaceutical companies, projects from practice are presented.

Registration

Background

New forms of and approaches to digitalisation are increasingly finding their way into the pharmaceutical industry. The automation stage is already well advanced, but topics such as AI, IOT and Industry 4.0 are waiting in the wings. Artificial Intelligence has arrived in the general public with Chat GPT and Bard, and it has also found its way into the pharmaceutical industry.
Therefore, the track will also be dedicated to Artificial Intelligence and present and discuss initial experience from established projects. The focus will be on GxP-relevant aspects from the perspective of the pharmaceutical industry and regulatory authorities against the backdrop of the EU GMP Guideline Annex 22 ‘Artificial Intelligence’ published on 7 July 2025.

Target Audience

The event is directed at specialists from the pharmaceutical industry as well as at engineers and planners who have to deal with digitalisation and AI projects.
It particularly addresses the departments:

• IT
• Production
• Quality assurance
• Engineering / Technology

Moderators

Stefan Münch, Körber Pharma Consulting
Yves Samson, Kereon